Freshfields advised Indivior PLC on its additional listing on NASDAQ. Indivior PLC (LSE: INDV), a global pharmaceutical company focused on developing medicines to treat substance use disorders (SUD)...
You must be a Standard 1 Year member to access this content.
Covington & Burling LLP advised Indivior, while Latham & Watkins LLP represented Opiant in the transaction. Opiant Pharmaceuticals Inc. (NASDAQ: OPNT) has entered into a definitive...
You must be a Standard 1 Year member to access this content.
Robbins Geller Rudman & Dowd, Seeger Weiss Newark, Plevin & Gallucci, Bertram & Graf, Irpino, Avin & Hawkins, Powell & Majestro, Dugan Law Firm, Cooper Law...
You must be a Standard 1 Year member to access this content.
